ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,438.42
      2.12%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.79
      -1.00%
      Bitcoin
      62,797.67
      6.22%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Rxi Pharmaceuticals Corp. (MM) (RXII)

      7. Rxi Pharmaceuticals Corp. (MM) (RXII) News

      RXII

      RXI Pharmaceuticals Corporation (RXII)

      Rxi Pharmaceuticals Corp. (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:RXII
      DateTimeSourceHeadlineSymbolCompany
      02/15/20197:15AMPR Newswire (US)Phio Pharmaceuticals Appoints Gerrit Dispersyn as New Chief Executive Officer Effective March 1NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      12/10/20189:35AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      11/26/20189:30AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      11/19/20185:52PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      11/14/20187:12AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      11/14/20187:10AMPR Newswire (US)RXi Pharmaceuticals Reports Third Quarter 2018 Financial Results and Recent Corporate HighlightsNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      11/14/20187:08AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      11/13/20185:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      11/13/20189:26AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      11/07/20187:05AMPR Newswire (US)RXi Pharmaceuticals to Present New Data Demonstrating the Ability of sd-rxRNA to Enhance NK Cell Activity for Adoptive Cell T...NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      11/06/20187:05AMPR Newswire (US)RXi Pharmaceuticals to Webcast Third Quarter 2018 Financial Results on Wednesday, November 14, 2018NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      10/29/20189:28AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      10/15/20189:26AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      10/10/20182:00PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      10/05/20185:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      10/03/20184:31PMPR Newswire (US)RXi Pharmaceuticals Announces Closing Of $15 Million Underwritten Public OfferingNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      10/02/20185:32PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      10/02/20185:30PMEdgar (US Regulatory)Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      10/01/201812:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      10/01/20186:39AMEdgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-1mef)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      10/01/20186:36AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      10/01/20186:10AMPR Newswire (US)RXi Pharmaceuticals Announces Pricing Of $15 Million Upsized Underwritten Public OfferingNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      09/28/20186:14AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      09/26/20188:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      09/26/20188:00AMPR Newswire (US)RXi Pharmaceuticals to Present New Data from its Immuno-Oncology Program Using sd-rxRNA Therapeutic Compounds Targeting Intra...NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      09/14/20185:48PMEdgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      09/14/20185:48PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      09/04/20187:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      08/31/20185:32PMEdgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      08/28/20189:15AMPR Newswire (US)RXi Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment ConferenceNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
       Showing the most relevant articles for your search:NASDAQ:RXII